Avalon GloboCare Stock Price - AVCO

Best deals to access real time data!
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
CHART Trader
Monthly Subscription
for only
$30.66
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
After Hours
Last Trade
Last $ 1.57 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Avalon GloboCare Corporation AVCO NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.02 -1.26% 1.57 1.62 1.55 1.60 1.59 19:59:41
Bid Price Ask Price Spread Spread % News
0.3457 2.65 2.30 86.95% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
330 47,836 $ 1.59 $ 76,268 54,861 1.41 - 13.50
Last Trade Time Type Quantity Stock Price Currency
15:59:44 formt 161 $ 1.57 USD

Avalon GloboCare Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 121.47M 77.37M $ -7.77M -0.11 - 25.62M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 68.40%

more financials information »

Avalon GloboCare News

Loading Messages....

Latest AVCO Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AVCO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.441.621.411.5439,5840.139.03%
1 Month1.601.721.411.5553,116-0.03-1.88%
3 Months1.862.651.411.9778,958-0.29-15.59%
6 Months2.282.801.412.17114,433-0.71-31.14%
1 Year2.7913.501.414.89267,523-1.22-43.73%
3 Years2.727413.501.414.89258,263-1.16-42.44%
5 Years2.727413.501.414.89258,263-1.16-42.44%

Avalon GloboCare Description

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promote and empower high impact, transformative biotechnology, and their clinical applications, and healthcare facility management. It has three reportable segments: real property operating segment which is the key revenue driver; medical-related consulting services segment; and development services and sales of developed products segment. The company focuses on the diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.


Your Recent History
NASDAQ
AVCO
Avalon Glo..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.